Ajay Hinduja Discusses Groundbreaking CAR-T Therapy Developments at P. D. Hinduja Hospital

P. D. Hinduja Hospital has achieved a groundbreaking milestone with its successful administration of allogeneic CAR-T therapy. The innovative NexCar-19 by ImmunoACT represents a significant leap toward making cancer care more affordable and accessible. Ajay Hinduja discusses the essential role of public-private partnerships in driving forward this innovative technology. He remarks, “The scientific ingenuity behind CAR-T therapy—particularly the use of Gamma-Delta T-cells—demonstrates how we can adapt treatments to meet the complexities of cancer. Such innovation paves the way for personalized medicine, where patients receive solutions tailored to their unique conditions.”